fda warning letter hims compounded semaglutide 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA takes aim at telehealth

Within my first years in medical practice, I developed curiosity on how to improve the support to patients with obesity besides just telling them to lose weight, said Dr

Finalmente, contar con "Compra Protegida" brinda una capa adicional de seguridad durante el proceso adquisitivo

The FDA endorsement of semaglutide for obstructive sleep apnea in 2025 further widened the eligible population, encouraging Medicare Advantage plans to drop previous exclusions

At Spa in the City, treatments are customized, monitored, and tailored to ensure safety and efficacy

These pens contain no antimicrobial preservatives, which is why proper storage matters so much

& Pohlig, C